Osiris Therapeutics (OSIR) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $14.8 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
